… harbor metastases at diagnosis and predicted the number and size distribution of metastases
as … pattern of pancreatic cancer metastasis is critical for designing effective interventions. …

… In this review, we discuss the current treatment options for metastatic pancreatic cancer
and highlight current ongoing clinical trials, which aim to target the stroma and the immune …

… Metastatic disease is the most critical determinant of resectability of pancreatic cancer and
… Thus, a better understanding of metastatic pancreatic cancer will afford new opportunities …

… FOLFIRINOX is an option for the treatment of patients with metastatic pancreatic cancer
and good performance status. (Funded by the French government and others; ClinicalTrials.gov …

… with metastatic pancreatic cancer? What is the appropriate therapy for patients with metastatic
pancreatic cancer … with prior regimens for metastatic pancreatic cancer? When should the …

… rearrangements in 13 patients with pancreatic cancer and explore clonal relationships
among metastases. We find that pancreatic cancer acquires rearrangements indicative of …

… Tumour biology of pancreatic cancer contributes to early recurrence and metastasis, and …
shown that about 90% of cases of pancreatic cancer are complicated by distant metastasis. …

… The aim of this work was to provide an update to the ASCO guideline on metastatic
pancreatic cancer pertaining to recommendations for therapy options after first-line treatment. …

Purpose In 2016, ASCO published a guideline to assist in clinical decision making in metastatic
pancreatic cancer for initial assessment after diagnosis, first- and second-line treatment …

… at an advanced or even metastatic state. Surgery is only … of metastasis is not appropriate
in pancreatic cancer outside of a clinical trial even in the case of isolated liver metastasis since …